Richard Daniell - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: Exec. VP, European Commercial
Signature: /s/ Dov Bergwerk as attorney-in-fact for Richard Daniell
Issuer symbol: TEVA
Transactions as of: 03 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2023, 15:03:16 UTC
Previous filing: 02 Mar 2023
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+15,921	+23%		85,691	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+33,512	+39%		119,203	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+22,576	+19%		141,779	05 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Award	$0	+249,003		$0.000000	249,003	03 Mar 2023	Ordinary Shares	249,003		Direct	F1, F2, F3
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-15,921	-100%	$0.000000^*	0	04 Mar 2023	Ordinary Shares	15,921		Direct	F1, F2, F4
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-33,512	-25%	$0.000000	100,536	04 Mar 2023	Ordinary Shares	33,512		Direct	F1, F2, F5
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-22,576	-33%	$0.000000	45,152	05 Mar 2023	Ordinary Shares	22,576		Direct	F1, F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Restricted share units were granted on March 3, 2023, with 62,250 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 62,253 vesting on March 3, 2027.
F4	Restricted share units were granted on March 4, 2019, with 15,920 vested on each of March 4, 2021 and March 4, 2022, and 15,921 vested on March 4, 2023.
F5	Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026.
F6	Restricted share units were granted on March 5, 2021, with 22,576 vested on each of March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025.